Literature DB >> 9207138

CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B.

W Kempf1, V Adams, N Wey, R Moos, M Schmid, E Avitabile, G Campadelli-Fiume.   

Abstract

Earlier studies have shown that Kaposi sarcomas contain cells infected with human herpesvirus (HHV) 6B, and in current studies we report that both AIDS-associated and classic-sporadic Kaposi sarcoma contain HHV-7 genome sequences detectable by PCR. To determine the distribution of HHV-7-infected cells relative to those infected with HHV-6, sections from paraffin-embedded tissues were allowed to react with antibodies to HHV-7 virion tegument phosphoprotein pp85 and to HHV-6B protein p101. The antibodies are specific for HHV-7 and HHV-6B, respectively, and they retained reactivity for antigens contained in formalin-fixed, paraffin-embedded tissue samples. We report that (i) HHV-7 pp85 was present in 9 of 32 AIDS-associated Kaposi sarcomas, and in 1 of 7 classical-sporadic HIV-negative Kaposi sarcomas; (ii) HHV-7 pp85 was detected primarily in cells bearing the CD68 marker characteristic of the monocyte/macrophage lineage present in or surrounding the Kaposi sarcoma lesions; and (iii) in a number of Kaposi sarcoma specimens, tumor-associated CD68+ monocytes/macrophages expressed simultaneously antigens from both HHV-7 and HHV-6B, and therefore appeared to be doubly infected with the two viruses. CD68+ monocytes/macrophages infected with HHV-7 were readily detectable in Kaposi sarcoma, but virtually absent from other normal or pathological tissues that harbor macrophages. Because all of the available data indicate that HHV-7 infects CD4+ T lymphocytes, these results suggest that the environment of the Kaposi sarcoma (i) attracts circulating peripheral lymphocytes and monocytes, triggers the replication of latent viruses, and thereby increases the local concentration of viruses, (ii) renders CD68+ monocytes/macrophages susceptible to infection with HHV-7, and (iii) the combination of both events enables double infections of cells with both HHV-6B and HHV-7.

Entities:  

Mesh:

Year:  1997        PMID: 9207138      PMCID: PMC23868          DOI: 10.1073/pnas.94.14.7600

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  55 in total

1.  Measurement of human herpesvirus 7 load in peripheral blood and saliva of healthy subjects by quantitative polymerase chain reaction.

Authors:  I M Kidd; D A Clark; M Ait-Khaled; P D Griffiths; V C Emery
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

2.  Isolation of a new herpesvirus from human CD4+ T cells.

Authors:  N Frenkel; E C Schirmer; L S Wyatt; G Katsafanas; E Roffman; R M Danovich; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

3.  Human herpesvirus 6 infection in renal transplantation.

Authors:  T Okuno; K Higashi; K Shiraki; K Yamanishi; M Takahashi; Y Kokado; M Ishibashi; S Takahara; T Sonoda; K Tanaka
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

4.  Determination and analysis of the complete nucleotide sequence of human herpesvirus.

Authors:  J Nicholas
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Variations in the replication and antigenic properties of human herpesvirus 6 strains.

Authors:  L S Wyatt; N Balachandran; N Frenkel
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

6.  Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes.

Authors:  R W Crowley; P Secchiero; D Zella; A Cara; R C Gallo; P Lusso
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

7.  Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals.

Authors:  D Di Luca; P Mirandola; T Ravaioli; R Dolcetti; A Frigatti; P Bovenzi; L Sighinolfi; P Monini; E Cassai
Journal:  J Med Virol       Date:  1995-04       Impact factor: 2.327

8.  Identification of an 85 kDa phosphoprotein as an immunodominant protein specific for human herpesvirus 7-infected cells.

Authors:  L Foà-Tomasi; M P Fiorilli; E Avitabile; G Campadelli-Fiume
Journal:  J Gen Virol       Date:  1996-03       Impact factor: 3.891

9.  Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: no evidence for an etiological association.

Authors:  W Kempf; V Adams; M Pfaltz; J Briner; M Schmid; R Moos; S Hassam
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

10.  Human herpes virus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer.

Authors:  B Ensoli; P Lusso; F Schachter; S F Josephs; J Rappaport; F Negro; R C Gallo; F Wong-Staal
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  15 in total

1.  Identification of human herpesvirus 6 latency-associated transcripts.

Authors:  Kazuhiro Kondo; Kazuya Shimada; Junji Sashihara; Keiko Tanaka-Taya; Koichi Yamanishi
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Recognition of a novel stage of betaherpesvirus latency in human herpesvirus 6.

Authors:  Kazuhiro Kondo; Junji Sashihara; Kazuya Shimada; Masaya Takemoto; Kiyoko Amo; Hiromi Miyagawa; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

3.  A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKε.

Authors:  Deguang Liang; Yuan Gao; Xianzhi Lin; Zhiheng He; Qinglan Zhao; Qiang Deng; Ke Lan
Journal:  Cell Res       Date:  2011-01-11       Impact factor: 25.617

4.  Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus.

Authors:  J Vieira; P O'Hearn; L Kimball; B Chandran; L Corey
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  The promotion of functional urinary bladder regeneration using anti-inflammatory nanofibers.

Authors:  Matthew I Bury; Natalie J Fuller; Jay W Meisner; Matthias D Hofer; Matthew J Webber; Lesley W Chow; Sheba Prasad; Hatim Thaker; Xuan Yue; Vani S Menon; Edward C Diaz; Samuel I Stupp; Earl Y Cheng; Arun K Sharma
Journal:  Biomaterials       Date:  2014-08-18       Impact factor: 12.479

6.  Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures.

Authors:  H Asada; V Klaus-Kovtun; H Golding; S I Katz; A Blauvelt
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

7.  Productive infection of primary macrophages with human herpesvirus 7.

Authors:  Y Zhang; L de Bolle; S Aquaro; A van Lommel; E De Clercq; D Schols
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Detection of a gene cluster that is dispensable for human herpesvirus 6 replication and latency.

Authors:  Kazuhiro Kondo; Hideo Nozaki; Kazuya Shimada; Koichi Yamanishi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 9.  Human herpesvirus 6: An emerging pathogen.

Authors:  G Campadelli-Fiume; P Mirandola; L Menotti
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

10.  Trafficking to the plasma membrane of the seven-transmembrane protein encoded by human herpesvirus 6 U51 gene involves a cell-specific function present in T lymphocytes.

Authors:  L Menotti; P Mirandola; M Locati; G Campadelli-Fiume
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.